Stifel Financial Corp lowered its holdings in shares of Endava plc (NYSE:DAVA – Free Report) by 8.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,740 shares of the company’s stock after selling 4,738 shares during the period. Stifel Financial Corp owned approximately 0.09% of Endava worth $1,296,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Blue Trust Inc. bought a new stake in shares of Endava during the third quarter valued at about $30,000. Signaturefd LLC increased its stake in Endava by 84.1% during the 3rd quarter. Signaturefd LLC now owns 1,939 shares of the company’s stock valued at $50,000 after buying an additional 886 shares during the period. Seven Eight Capital LP acquired a new position in Endava during the 2nd quarter valued at about $216,000. Precision Wealth Strategies LLC raised its position in shares of Endava by 6.7% during the 3rd quarter. Precision Wealth Strategies LLC now owns 8,571 shares of the company’s stock worth $219,000 after buying an additional 540 shares in the last quarter. Finally, Strengthening Families & Communities LLC lifted its stake in shares of Endava by 11.4% in the 3rd quarter. Strengthening Families & Communities LLC now owns 9,116 shares of the company’s stock worth $233,000 after acquiring an additional 933 shares during the period. Institutional investors and hedge funds own 62.23% of the company’s stock.
Endava Price Performance
NYSE DAVA opened at $30.30 on Friday. Endava plc has a 1 year low of $23.28 and a 1 year high of $81.06. The stock’s 50-day moving average price is $27.49 and its two-hundred day moving average price is $28.38. The company has a market cap of $1.79 billion, a PE ratio of 216.43, a PEG ratio of 2.16 and a beta of 1.24. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.
Wall Street Analyst Weigh In
A number of research firms recently commented on DAVA. Needham & Company LLC raised their price objective on shares of Endava from $33.00 to $36.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Susquehanna lowered their price target on Endava from $66.00 to $55.00 and set a “positive” rating on the stock in a research report on Friday, September 20th. JPMorgan Chase & Co. upped their price objective on Endava from $41.00 to $47.00 and gave the company an “overweight” rating in a report on Friday, September 6th. TD Cowen raised their target price on Endava from $35.00 to $36.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, Bank of America began coverage on shares of Endava in a research report on Friday, November 22nd. They issued a “neutral” rating and a $29.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $39.83.
Read Our Latest Report on Endava
Endava Profile
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading
- Five stocks we like better than Endava
- Consumer Staples Stocks, Explained
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 12/16 – 12/20
Want to see what other hedge funds are holding DAVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endava plc (NYSE:DAVA – Free Report).
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.